29 results on '"Bejan‐Angoulvant, Théodora"'
Search Results
2. Catheter-based renal denervation in the treatment of arterial hypertension: An expert consensus statement on behalf of the French Society of Hypertension (SFHTA), French Society of Radiology (SFR), French Society of Interventional Cardiology (GACI), French Society of Cardiology (SFC), French Association of Private Cardiologists (CNCF), French Association of Hospital Cardiologists (CNCH), French Society of Thoracic and Cardiovascular Surgery (SFCTCV) and French Society of Vascular and Endovascular Surgery (SCVE)
3. Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis
4. Recommandations sur la mesure de la pression artérielle. Consensus d’experts de la Société française d’hypertension artérielle, filiale de la Société française de cardiologie
5. Hormones endogènes et exogènes
6. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials
7. Les imperfections actuelles des traitements antihypertenseurs et leur correction
8. Ischaemic postconditioning reduces infarct size: Systematic review and meta-analysis of randomized controlled trials
9. Information et communication sur les risques liés au médicament et son bon usage auprès des professionnels de santé et du public : principe de précaution, gestion du risque, communication pendant et en dehors des situations de crise
10. Information and Communication on Risks Related to Medications and Proper Use of Medications for Healthcare Professionals and the General Public: Precautionary Principle, Risk Management, Communication During and in the Absence of Crisis Situations
11. Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial
12. The IDEAL Study : Towards Personalized Drug Treatment of Hypertension
13. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
14. Hazard Regression Model and Cure Rate Model in Colon Cancer Relative Survival Trends: Are They Telling the Same Story?
15. Critique du modèle additif de l’essai clinique randomisé
16. Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature
17. The best in coronary artery disease management is yet to come
18. Do We Need to Assess the Effect of Treatment Withdrawal?: The Paradigm of Life-Long Prevention
19. GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
20. Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients
21. Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings
22. Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
23. False positive results in preclinical research
24. USE OF MODERN SCORES TO EVALUATE INDIVIDUAL RISK/BENEFIT OF PROLONGED DUAL ANTIPLATELET THERAPY MAY MODIFY DUAL ANTI-PLATELET THERAPY DURATION IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS
25. 0191: Cardiovascular events and bleeding risk associated with intravitreal anti-VEGF monoclonal antibodies: systematic review and meta-analysis
26. 049 Invasive detection of myocardial microvascular disease in patients with end stage renal disease. The MICROCARD study
27. 043 Does routine measurement of ankle brachial index ameliorates the assessment of coronary risk level in patients with known or suspected coronary artery disease. The ABICARD study
28. Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER‐ILD study)
29. Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.